Results 101 to 110 of about 385,596 (219)

Vaccine [PDF]

open access: yes
Concurrent outbreaks of circulating vaccine-derived poliovirus serotypes 1 and 2 (cVDPV1, cVDPV2) were confirmed in the Republic of the Philippines in September 2019 and were subsequently confirmed in Malaysia by early 2020.

core  

Evolution of a rare vaccine-derived multirecombinant poliovirus

open access: yes, 2005
Recombination is one of the mechanisms by which viral genomes evolve. A vaccine-derived multirecombinant poliovirus strain was isolated from a 5-month-old child with vaccine-associated paralytic poliomyelitis after oral poliovirus vaccine administration.
Markoulatos, P.   +2 more
core   +1 more source

Impediments to Progress Toward Polio Eradication During 2014–2024: Effectively Addressing the Current Challenges

open access: yesVaccines
When the Global Polio Eradication Initiative (GPEI) began in 1988, the year 2000 target was clearly ambitious. Nonetheless, among 20 countries with endemic wild poliovirus transmission in 2000, only Afghanistan, Nigeria and Pakistan remained endemic in ...
Steven G. F. Wassilak   +2 more
doaj   +1 more source

Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis? [PDF]

open access: yesFront Public Health, 2023
Devaux CA   +4 more
europepmc   +1 more source

S2M: A Stochastic Simulation Model of Poliovirus Genetic State Transition

open access: yes, 2016
Modeling the molecular mechanisms that govern genetic variation can be useful in understanding the dynamics that drive genetic state transition in quasispecies viruses.
Carol L. Ecale Zhou
core   +1 more source

Leukocyte Differential Count Of Long·Talled Macaques (Macacafascicularis)Experimentally Infected With Poliovirus [PDF]

open access: yes, 2017
This research intended to know the effect of injected poliovirus against long-tailed monkeys' leukocyte differential countand whether there is any significant difference in the impact between OPV2 vaccine and WHO Reference poliovirus.
Stefani Ariesa Wara Hapsari
core  

Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial. [PDF]

open access: yesLancet Infect Dis, 2023
Wilkinson AL   +19 more
europepmc   +1 more source

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children. [PDF]

open access: yesJ Infect Dis, 2022
Tagbo BN   +16 more
europepmc   +1 more source

Notes from the Field: House-to-House Campaign Administration of Inactivated Poliovirus Vaccine - Sokoto State, Nigeria, November 2022. [PDF]

open access: yesMMWR Morb Mortal Wkly Rep, 2023
Biya O   +11 more
europepmc   +1 more source

Emerg Infect Dis

open access: yes
Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine.

core  

Home - About - Disclaimer - Privacy